Abstract
Under dynamic observation were 147 patients with IHD and VA (Lown II-IV functional class). The diagnosis of angina pectoris was confirmed by clinical, exercise bicycle ergometry, Holter ECG monitoring, and echocardiography data. Holter ECG monitoring was used for recording VA, heart rate, episodes of ST-segment depression. The levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDLC), high-density lipoprotein cholesterol were determined. All patients were randomly divided into 2 groups. The first group (81 patients) received standard antianginal and antiarrhythmic therapy plus meldonium for 2 months. The second (control) group (66 patients) received standard antianginal and antiarrhythmic therapy only. Statistical analysis of the data was carried out using the statistical package SPSS 13.0. A comparative analysis of the results showed that the use of meldonium in combination with basic therapy significantly improved clinical condition and quality of life indicators, increased exercise tolerance and improved systolic and diastolic dysfunction in patients with IHD and VA. The positive effect of meldonium on LDLC levels was observed. Moreover, the combination of basic antianginal and antiarrhythmic therapy and meldonium in patients with ischemic genesis VA promoted significant reduction of ischemic episodes and decrease of VA, in particular allorhythmia. Results of this study suggest that the use of meldonium in patients with IHD and VA helps to optimize myocardial energy metabolism in conditions of ischemia and reperfusion.
Highlights
Целью данной работы является оценка эффективности применения мельдония у больных ишемической болезнью сердца (ИБС) с желудочковой экстрасистолией
Results of this study suggest that the use of meldonium in patients with Ischemic heart disease (IHD) and ventricular arrhythmias (VA) helps to optimize myocardial energy metabolism in conditions of ischemia and reperfusion
И желудочковыми экстрасистолами (II–IV градации по Lown)
Summary
Целью данной работы является оценка эффективности применения мельдония у больных ишемической болезнью сердца (ИБС) с желудочковой экстрасистолией. Для оценки ишемии миокарда у больных ИБС определяли суммарное количество ишемических эпизодов на ЭКГ. Сравнительная оценка некоторых эхокардиографических показателей, характеризующих структурнофункциональное состояние левых отделов сердца у больных основной и контрольной группы до и после 2‐месячной терапии
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
